Neuroinflammation essentially involves an activation of glial cells as the cause/effect of
neurodegenerative diseases such as Alzheimer's disease (AD). Plasmalogens (Pls) are …

Aside from accumulation of amyloid-ß (Aß) peptide in the brain, Alzheimer's disease (AD)
has been reported as being associated with peroxidation of major phospholipids (eg …

Background: Choline alphoscerate (alpha glyceryl phosphorylcholine, α-GPC) is a choline-
containing phospholipid used as a medicine or nutraceutical to improve cognitive function …

Abstract Hypothesis We hypothesized that Lomecel‐B, an allogeneic medicinal signaling
cell (MSC) therapeutic candidate for Alzheimer's disease (AD), is safe and potentially …

Alzheimer's disease (AD) is the most common form of neurodegenerative dementia and
there is no cure to date. Biomarkers in cerebrospinal fluid (CSF) are already included in the …

Introduction We report previously unpublished, early pilot studies performed with a brain-
health food supplement containing a proprietary blend of 100 mg phosphatidylserine (PS) …

Abstract Objective The effects of (−)‐phenserine (phenserine) and placebo/donepezil
treatment on regional cerebral metabolic rate for glucose (rCMRglc) and brain amyloid load …

As neuroinflammation is an early event in the pathogenesis of Alzheimer's disease, new
selective antiinflammatory drugs could lead to promising preventive strategies. We …

Alzheimer's disease (AD) is a progressive, neurodegenerative disease, characterised by
decline of memory, cognitive function and changes in behaviour. Generic markers of lipid …

OBJECTIVE: To investigate the effect of a medical food on cognitive function in people with
mild Alzheimer's disease (AD). METHODS: A total of 225 drug-naïve AD patients …